Dharmacon RNAi Technology Selected to Support Drug Discovery Research

Dharmacon, the world's leading supplier of innovative RNA and RNA interference (RNAi) research products, has announced that Genentech has selected Dharmacon's advanced RNAi technology for use in its drug discovery and development research. Under an agreement between the two companies, Dharmacon will supply Genentech with a range of siRNA reagents including Dharmacon's Human Druggable Genome library, which focuses on those genes that are considered potential targets for therapeutics.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/01-21-2005/0002869618&EDATE=)